Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Capio France Joins Groupe Hospitalier Paris Saint-Joseph as an Early Adopter of Medworxx in France

C.RGX

Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX), a leading healthcare patient flow software solutions provider, is pleased to announce that Capio France has selected Medworxx as their Patient Flow software provider.

“After assessing the Medworxx solution we clearly recognize the benefit of the solution within the private hospital sector within the France Market. Capio continues to be innovative with respect to improving quality outcomes while increasing efficiencies especially in the area of Length of Stay,” said Francois Demesmay, Chief Operations Officer, Capio France. “The Medworxx solution is proven internationally and after completing the Average Length of Stay Audit with Medworxx we see the applicability of the Patient Flow Platform for us. We are excited to be an early adopter of this solution in France and for Capio internationally.”

“Capio is one of Europe’s most respected private healthcare providers. This is another step toward validation that the Medworxx Clinical Criteria solution is effective across international geographies for both public and private healthcare providers,” said Niels Tofting, SVP, Business Development, Medworxx.

The Medworxx Clinical Criteria module will enable the hospital to identify the clinical appropriateness of each patient’s level of care, each day, and will provide clinicians with the ability to match patients with the right level of care, at the right time and in the most appropriate setting. The solution combines a unique methodology, process, communication, technology, and clinical information as a decision support tool for all levels of an organization. The Medworxx Patient Flow Platform provides hospitals with tools to bridge clinical and operational perspectives on daily patient flow –addressing issues of overcapacity, wait times and care coordination.

About Capio Group
Via hospitals, specialist clinics and primary care units, Capio offers a broad range of high quality medical, surgical and psychiatric healthcare. Capio operations are located in four countries, Sweden, Norway, France and Germany. In 2013 Capio received more than 4.3 million patient visits. Capio France consists of 22 “cliniques”, the name for hospitals and specialist clinics run by private healthcare providers in France. The seven emergency hospitals, twelve local hospitals and three specialist clinics are located in eight regions of the country, south-western and eastern France, and the Paris area.

About Medworxx
Medworxx delivers health information technology solutions to over 350 hospitals internationally, including Canada, United States, United Kingdom, France and Australia. Medworxx helps hospitals meet patient flow challenges and requirements for compliance and education. Medworxx Clinical Criteria —the flagship component of Medworxx Patient Flow, which also includes electronic bed management and independent assessment components—is currently used to manage 34% of the acute-care beds in Canada as well as acute-care beds in a rapidly increasing number of Trusts and CCGs in the UK. Founded in 2004, Medworxx Inc. is based in Toronto, Canada, and publicly traded on the TSX Venture Exchange: MWX. Visit: www.medworxx.com

Disclaimer
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.

Medworxx
Dan Matlow, 416-642-1278 x311
President & Chief Executive Officer
1-800-321-1591
dmatlow@medworxx.com
or
Nadine Brown, 416-642-1278 x317
Director of Marketing
1-800-321-1591
nbrown@medworxx.com

www.medworxx.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today